About EMI domain-containing protein 1
EMI domain-containing protein 1 (EMID1) is a protein
from Homo sapiens identified by UniProt accession
Q96A84, 441 residues long.
MolForge cross-references it against 0 known binders and
37 disease associations.
Target properties
| Protein name | EMI domain-containing protein 1 |
|---|
| UniProt accession | Q96A84 |
|---|
| Gene | EMID1 |
|---|
| Organism | Homo sapiens |
|---|
| Length | 441 residues |
|---|
| Molecular weight | — |
|---|
| EC numbers | — |
|---|
| Target class | UNCLASSIFIED |
|---|
| Subcellular location | — |
|---|
| Keywords | — |
|---|
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
|---|
| Druggability score | — |
|---|
| Pocket score | — |
|---|
| Max clinical phase | — |
|---|
Disease associations (37)
Diseases linked to this target (Open Targets).
- intraocular pressure measurement · score 0.43
- monocyte count · score 0.39
- reticulocyte count · score 0.38
- leukocyte count · score 0.37
- breast carcinoma · score 0.36
- lymphocyte count · score 0.33
- reticulocyte measurement · score 0.33
- platelet count · score 0.31
- Red cell distribution width · score 0.29
- neutrophil count · score 0.28
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
|---|
| AF-Q96A84-F1 | alphafold | PREDICTED | 51.63 | — |
Amino-acid sequence (441 residues)
MGGPRAWALL CLGLLLPGGG AAWSIGAAPF SGRRNWCSYV VTRTISCHVQ NGTYLQRVLQ NCPWPMSCPG SSYRTVVRPT YKVMYKIVTA REWRCCPGHS GVSCEEASSA SLEPMWSGST MRRMALRPTA FSGCLNCSKV SELTERLKVL EAKMTMLTVI EQPVPPTPAT PEDPAPLWGP PPAQGSPGDG GLQDQVGAWG LPGPTGPKGD AGSRGPMGMR GPPGPQGPPG SPGRAGAVGT PGERGPPGPP GPPGPPGPPA PVGPPHARIS QHGDPLLSNT FTETNNHWPQ GPTGPPGPPG PMGPPGPPGP TGVPGSPGHI GPPGPTGPKG ISGHPGEKGE RGLRGEPGPQ GSAGQRGEPG PKGDPGEKSH WGEGLHQLRE ALKILAERVL ILETMIGLYE PELGSGAGPA GTGTPSLLRG KRGGHATNYR IVAPRSRDER G
Explore EMI domain-containing protein 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets